Logo image of AMTM

AMENTUM HOLDINGS INC (AMTM) Stock Fundamental Analysis

NYSE:AMTM - US0239391016 - Common Stock

24.98 USD
+0.03 (+0.12%)
Last: 9/2/2025, 8:04:00 PM
25.04 USD
+0.06 (+0.24%)
After Hours: 9/2/2025, 8:04:00 PM
Fundamental Rating

3

Taking everything into account, AMTM scores 3 out of 10 in our fundamental rating. AMTM was compared to 83 industry peers in the Professional Services industry. Both the profitability and financial health of AMTM have multiple concerns. AMTM has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

AMTM had positive earnings in the past year.
In the past year AMTM had a positive cash flow from operations.
AMTM Yearly Net Income VS EBIT VS OCF VS FCFAMTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 100M -100M 200M -200M -300M

1.2 Ratios

AMTM has a Return On Assets (0.44%) which is comparable to the rest of the industry.
The Return On Equity of AMTM (1.17%) is comparable to the rest of the industry.
AMTM has a Return On Invested Capital of 2.48%. This is in the lower half of the industry: AMTM underperforms 61.45% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AMTM is significantly below the industry average of 12.57%.
The last Return On Invested Capital (2.48%) for AMTM is above the 3 year average (2.31%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.44%
ROE 1.17%
ROIC 2.48%
ROA(3y)-2.27%
ROA(5y)N/A
ROE(3y)-33%
ROE(5y)N/A
ROIC(3y)2.31%
ROIC(5y)N/A
AMTM Yearly ROA, ROE, ROICAMTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

AMTM has a Profit Margin (0.41%) which is in line with its industry peers.
AMTM has a Operating Margin (2.39%) which is in line with its industry peers.
AMTM's Operating Margin has been stable in the last couple of years.
AMTM's Gross Margin of 10.21% is on the low side compared to the rest of the industry. AMTM is outperformed by 85.54% of its industry peers.
AMTM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.39%
PM (TTM) 0.41%
GM 10.21%
OM growth 3Y-0.75%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.94%
GM growth 5YN/A
AMTM Yearly Profit, Operating, Gross MarginsAMTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 5 10

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AMTM is destroying value.
Compared to 1 year ago, AMTM has more shares outstanding
Compared to 1 year ago, AMTM has an improved debt to assets ratio.
AMTM Yearly Shares OutstandingAMTM Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 50M 100M 150M 200M
AMTM Yearly Total Debt VS Total AssetsAMTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

AMTM has an Altman-Z score of 1.72. This is a bad value and indicates that AMTM is not financially healthy and even has some risk of bankruptcy.
AMTM has a worse Altman-Z score (1.72) than 69.88% of its industry peers.
The Debt to FCF ratio of AMTM is 32.53, which is on the high side as it means it would take AMTM, 32.53 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 32.53, AMTM is not doing good in the industry: 67.47% of the companies in the same industry are doing better.
AMTM has a Debt/Equity ratio of 1.00. This is a neutral value indicating AMTM is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 1.00, AMTM is not doing good in the industry: 68.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF 32.53
Altman-Z 1.72
ROIC/WACC0.28
WACC8.79%
AMTM Yearly LT Debt VS Equity VS FCFAMTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 1.58 indicates that AMTM should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.58, AMTM is in line with its industry, outperforming 59.04% of the companies in the same industry.
AMTM has a Quick Ratio of 1.58. This is a normal value and indicates that AMTM is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of AMTM (1.58) is better than 61.45% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.58
AMTM Yearly Current Assets VS Current LiabilitesAMTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

AMTM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 83.53%, which is quite impressive.
AMTM shows a small growth in Revenue. In the last year, the Revenue has grown by 6.65%.
The Revenue has been growing by 12.53% on average over the past years. This is quite good.
EPS 1Y (TTM)83.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%124.64%
Revenue 1Y (TTM)6.65%
Revenue growth 3Y12.53%
Revenue growth 5YN/A
Sales Q2Q%66.25%

3.2 Future

The Earnings Per Share is expected to grow by 72.63% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 2.51% on average over the next years.
EPS Next Y317.31%
EPS Next 2Y114.95%
EPS Next 3Y72.63%
EPS Next 5YN/A
Revenue Next Year2.65%
Revenue Next 2Y1.82%
Revenue Next 3Y2.51%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AMTM Yearly Revenue VS EstimatesAMTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B
AMTM Yearly EPS VS EstimatesAMTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.5 1 1.5 2 2.5

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.07, AMTM is valued correctly.
Based on the Price/Earnings ratio, AMTM is valued cheaper than 84.34% of the companies in the same industry.
When comparing the Price/Earnings ratio of AMTM to the average of the S&P500 Index (26.90), we can say AMTM is valued rather cheaply.
A Price/Forward Earnings ratio of 10.19 indicates a reasonable valuation of AMTM.
Based on the Price/Forward Earnings ratio, AMTM is valued cheaper than 83.13% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.52, AMTM is valued rather cheaply.
Industry RankSector Rank
PE 12.07
Fwd PE 10.19
AMTM Price Earnings VS Forward Price EarningsAMTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AMTM is valued a bit cheaper than the industry average as 63.86% of the companies are valued more expensively.
AMTM's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. AMTM is more expensive than 62.65% of the companies in the same industry.
Industry RankSector Rank
P/FCF 44.1
EV/EBITDA 13.06
AMTM Per share dataAMTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AMTM's earnings are expected to grow with 72.63% in the coming years.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2Y114.95%
EPS Next 3Y72.63%

0

5. Dividend

5.1 Amount

AMTM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMENTUM HOLDINGS INC

NYSE:AMTM (9/2/2025, 8:04:00 PM)

After market: 25.04 +0.06 (+0.24%)

24.98

+0.03 (+0.12%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)12-16 2025-12-16
Inst Owners62.75%
Inst Owner Change4.41%
Ins Owners0.56%
Ins Owner Change1.56%
Market Cap6.08B
Analysts74.67
Price Target27.54 (10.25%)
Short Float %5.34%
Short Ratio5.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.54%
Min EPS beat(2)2.91%
Max EPS beat(2)10.16%
EPS beat(4)4
Avg EPS beat(4)26.92%
Min EPS beat(4)2.91%
Max EPS beat(4)84.31%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.42%
Min Revenue beat(2)-0.61%
Max Revenue beat(2)-0.23%
Revenue beat(4)2
Avg Revenue beat(4)0.41%
Min Revenue beat(4)-0.61%
Max Revenue beat(4)2.38%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.11%
PT rev (3m)11.18%
EPS NQ rev (1m)0.2%
EPS NQ rev (3m)0.23%
EPS NY rev (1m)1.25%
EPS NY rev (3m)2.55%
Revenue NQ rev (1m)-0.05%
Revenue NQ rev (3m)-0.19%
Revenue NY rev (1m)0.33%
Revenue NY rev (3m)0.15%
Valuation
Industry RankSector Rank
PE 12.07
Fwd PE 10.19
P/S 0.48
P/FCF 44.1
P/OCF 37.99
P/B 1.36
P/tB N/A
EV/EBITDA 13.06
EPS(TTM)2.07
EY8.29%
EPS(NY)2.45
Fwd EY9.81%
FCF(TTM)0.57
FCFY2.27%
OCF(TTM)0.66
OCFY2.63%
SpS52.11
BVpS18.32
TBVpS-13.29
PEG (NY)0.04
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.44%
ROE 1.17%
ROCE 3.14%
ROIC 2.48%
ROICexc 2.69%
ROICexgc 19.81%
OM 2.39%
PM (TTM) 0.41%
GM 10.21%
FCFM 1.09%
ROA(3y)-2.27%
ROA(5y)N/A
ROE(3y)-33%
ROE(5y)N/A
ROIC(3y)2.31%
ROIC(5y)N/A
ROICexc(3y)2.45%
ROICexc(5y)N/A
ROICexgc(3y)14.93%
ROICexgc(5y)N/A
ROCE(3y)2.92%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.75%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.94%
GM growth 5YN/A
F-Score6
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF 32.53
Debt/EBITDA 5.91
Cap/Depr 4.94%
Cap/Sales 0.17%
Interest Coverage 250
Cash Conversion 21.28%
Profit Quality 264.03%
Current Ratio 1.58
Quick Ratio 1.58
Altman-Z 1.72
F-Score6
WACC8.79%
ROIC/WACC0.28
Cap/Depr(3y)5.55%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.2%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)83.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%124.64%
EPS Next Y317.31%
EPS Next 2Y114.95%
EPS Next 3Y72.63%
EPS Next 5YN/A
Revenue 1Y (TTM)6.65%
Revenue growth 3Y12.53%
Revenue growth 5YN/A
Sales Q2Q%66.25%
Revenue Next Year2.65%
Revenue Next 2Y1.82%
Revenue Next 3Y2.51%
Revenue Next 5YN/A
EBIT growth 1Y16.17%
EBIT growth 3Y11.69%
EBIT growth 5YN/A
EBIT Next Year106.14%
EBIT Next 3Y31.79%
EBIT Next 5YN/A
FCF growth 1Y-30.5%
FCF growth 3Y-45.82%
FCF growth 5YN/A
OCF growth 1Y-30.26%
OCF growth 3Y-42.49%
OCF growth 5YN/A